Source: Indian Pharma Post

Pierre Fabre: Jubilant Biosys signs and issues a put option offer to Pierre Fabre Laboratories

The acquisition will strengthen the overall company's position as leading global CRO services partner

Read full article »
Est. Annual Revenue
$1.0-5.0B
Est. Employees
10-50K
Eric Ducournau's photo - CEO of Pierre Fabre

CEO

Eric Ducournau

CEO Approval Rating

77/100

Read more